BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14727932)

  • 1. New anticoagulants: current status and future potential.
    Weitz JI; Crowther MA
    Am J Cardiovasc Drugs; 2003; 3(3):201-9. PubMed ID: 14727932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anticoagulants for venous thromboembolic disease.
    Chang P
    IDrugs; 2004 Jan; 7(1):50-7. PubMed ID: 14730467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antithrombotics in the prevention of thromboembolic disease.
    Yavin YY; Wolozinsky M; Cohen AT
    Eur J Intern Med; 2005 Aug; 16(4):257-66. PubMed ID: 16084352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anticoagulants.
    Bauer KA
    Hematology Am Soc Hematol Educ Program; 2006; ():450-6. PubMed ID: 17124098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging anticoagulants.
    Kennedy B; Gargoum FS; Kennedy L; Khan F; Curran DR; O'Connor TM
    Curr Med Chem; 2012; 19(20):3388-416. PubMed ID: 22680641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticoagulants.
    Weitz JI; Bates SM
    J Thromb Haemost; 2005 Aug; 3(8):1843-53. PubMed ID: 16102051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New anticoagulants].
    Kawasaki T; Hirayama F
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):275-82. PubMed ID: 11215377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current anticoagulant therapy--unmet clinical needs.
    Hirsh J
    Thromb Res; 2003 Jul; 109 Suppl 1():S1-8. PubMed ID: 12818628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of coagulation factors: advances in antithrombotic therapy.
    Bauer KA
    Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Factor Xa : a potential target for the development of new anticoagulants.
    Alexander JH; Singh KP
    Am J Cardiovasc Drugs; 2005; 5(5):279-90. PubMed ID: 16156684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulants: anti IIa vs anti Xa--is one better?
    Bauer KA
    J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
    Raaz U; Kaeberich A; Maegdefessel L; Buerke M; Busshardt M; Schubert S; Russ M; Plehn A; Ebelt H; Werdan K; Schlitt A
    Thromb Haemost; 2010 Apr; 103(4):808-14. PubMed ID: 20174756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anticoagulants.
    Hirsh J; O'Donnell M; Weitz JI
    Blood; 2005 Jan; 105(2):453-63. PubMed ID: 15191946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
    Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.